Assignee
PROGENICS PHARM INC
US63 patents
Top patents by PatentIndex Score
US10340046B2Jul 2, 2019
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
PROGENICS PHARM INC32 citations98
US6344545B1Feb 5, 2002
Method for preventing HIV-1 infection of CD4+ cells
PROGENICS PHARM INC91 citations97
US6261763B1Jul 17, 2001
Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion
PROGENICS PHARM INC38 citations96
US6107019AAug 22, 2000
Method for preventing HIV-1 infection of CD4+ cells
PROGENICS PHARM INC78 citations96
US6034223AMar 7, 2000
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
PROGENICS PHARM INC69 citations96
US5817767AOct 6, 1998
Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
PROGENICS PHARM INC73 citations96
US11894141B2Feb 6, 2024
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
PROGENICS PHARM INC11 citations95
US7674904B2Mar 9, 2010
Synthesis of R-N-methylnaltrexone
PROGENICS PHARM INC52 citations95
US6710173B1Mar 23, 2004
Stabilized viral envelope proteins and uses thereof
PROGENICS PHARM INC36 citations95
US11424035B2Aug 23, 2022
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
PROGENICS PHARM INC18 citations94
US10762993B2Sep 1, 2020
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
PROGENICS PHARM INC25 citations94
US10665346B2May 26, 2020
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
PROGENICS PHARM INC25 citations94
US7138119B2Nov 21, 2006
Compositions and methods for inhibition of HIV-1 infection
PROGENICS PHARM INC24 citations93
US7060273B2Jun 13, 2006
Methods for inhibiting HIV-1 infection
PROGENICS PHARM INC32 citations93
US6692745B2Feb 17, 2004
Compositions and methods for inhibition of HIV-1 infection
PROGENICS PHARM INC37 citations93
US6548636B2Apr 15, 2003
Sulfated CCR5 peptides for HIV-1 infection
PROGENICS PHARM INC54 citations93
US11534125B2Dec 27, 2022
Systems and methods for automated and interactive analysis of bone scan images for detection of metastases
PROGENICS PHARM INC15 citations92
US10973486B2Apr 13, 2021
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
PROGENICS PHARM INC41 citations92
US7939083B2May 10, 2011
Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain
PROGENICS PHARM INC55 citations92
US7563899B2Jul 21, 2009
(S)-N-methylnaltrexone
PROGENICS PHARM INC36 citations92
US7345153B2Mar 18, 2008
Compounds capable of inhibiting HIV-1 infection
PROGENICS PHARM INC23 citations92
US7118859B2Oct 10, 2006
Methods for inhibiting HIV-1 infection
PROGENICS PHARM INC30 citations92
US6972126B2Dec 6, 2005
Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same
PROGENICS PHARM INC33 citations92
US7666419B2Feb 23, 2010
Anti-CCR5 antibody
PROGENICS PHARM INC14 citations91
US7592014B2Sep 22, 2009
Stabilized viral envelope proteins and uses thereof
PROGENICS PHARM INC34 citations91
US7022324B2Apr 4, 2006
Stabilized viral envelope proteins and uses thereof
PROGENICS PHARM INC31 citations91
US6451313B1Sep 17, 2002
CD4-gamma2 and CD4-IGG2 chimeras
PROGENICS PHARM INC29 citations91
US5886163AMar 23, 1999
HIV-1 antigens, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
PROGENICS PHARM INC17 citations91
US8343992B2Jan 1, 2013
Synthesis of R-N-methylnaltrexone
PROGENICS PHARM INC14 citations90
US12224067B1Feb 11, 2025
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
PROGENICS PHARM INC7 citations86
US11900597B2Feb 13, 2024
Systems and methods for artificial intelligence-based image analysis for cancer assessment
PROGENICS PHARM INC12 citations84
US11564621B2Jan 31, 2023
Systems and methods for artificial intelligence-based image analysis for cancer assessment
PROGENICS PHARM INC19 citations84
US11544407B1Jan 3, 2023
Systems and methods for secure cloud-based medical image upload and processing
PROGENICS PHARM INC10 citations84
US11937962B2Mar 26, 2024
Systems and methods for automated and interactive analysis of bone scan images for detection of metastases
PROGENICS PHARM INC11 citations83
US9669096B2Jun 6, 2017
Stable pharmaceutical formulations of methylnaltrexone
PROGENICS PHARM INC5 citations82
US9597327B2Mar 21, 2017
Synthesis of (R)-N-methylnaltrexone
PROGENICS PHARM INC5 citations82
US12431246B2Sep 30, 2025
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
PROGENICS PHARM INC2 citations75
US6177549B1Jan 23, 2001
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
PROGENICS PHARM INC10 citations74
US6083478AJul 4, 2000
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 Immunoconjugates, and uses thereof
PROGENICS PHARM INC9 citations74
US12417533B2Sep 16, 2025
Systems and methods for artificial intelligence-based image analysis for cancer assessment
PROGENICS PHARM INC4 citations73
US12414748B2Sep 16, 2025
Systems and methods for automated and interactive analysis of bone scan images for detection of metastases
PROGENICS PHARM INC3 citations72
US7479553B2Jan 20, 2009
Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins
PROGENICS PHARM INC4 citations72
US6187748B1Feb 13, 2001
Uses of CD4-gamma2 and CD4-IgG2 chimeras
PROGENICS PHARM INC9 citations72
US5869624AFeb 9, 1999
HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
PROGENICS PHARM INC13 citations72
US10376584B2Aug 13, 2019
Stable pharmaceutical formulations of methylnaltrexone
PROGENICS PHARM INC2 citations71
US9102680B2Aug 11, 2015
Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
PROGENICS PHARM INC4 citations71
US8003794B2Aug 23, 2011
(S)-N-methylnaltrexone
PROGENICS PHARM INC4 citations69
US7851600B2Dec 14, 2010
Anti-CCR5 antibody
PROGENICS PHARM INC3 citations63
US7022323B2Apr 4, 2006
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
PROGENICS PHARM INC3 citations63
US6737267B2May 18, 2004
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
PROGENICS PHARM INC3 citations63
Showing the top 50 of 63 patents by PatentIndex Score.